COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2393-9079

Online ISSN:-2393-9087

CODEN : IJPPTK

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 696

Emailed: 0

PDF Downloaded: 302

Indian Journal of Pharmacy and Pharmacology


To compare the safety and efficacy of diacerein and oxaceprol in the management of grade I & II osteoarthritis of knee


Full Text PDF Share on Facebook Share on Twitter


Author Details : Satyendra Sharad, Dinesh Kansal*, Vipin Sharma, Parveen Sharma

Volume : 5, Issue : 3, Year : 2018

Article Page : 105-109


Suggest article by email


Abstract

Introduction: Diacerein and oxaceprol are frequently used for the treatment of Grade-I & II osteoarthritis of knees. Diacerein acts by blocking the action of interleukin-1 whereas oxaceprol prevents leukocyte infiltration in the synovial joints. Both the drugs are effective. But there are few comparative studies regarding safety and efficacy of these two drugs. Hence we planned this study.
Materials and Methods: An open label randomized comparative study was conducted by the departments of Pharmacology and Orthopedics at Dr RPGMC, Tanda, H.P, after taking permission from the IEC. Patients were diagnosed clinically as per American College of Rheumatology (ACR) guidelines and graded radiologically as Grade I & II osteoarthritis of the knee joint based on Kellgren and Lawrence classification. Then considering exclusion criteria, patients were enrolled after taking written informed consent. 31 and 29 patients were enrolled in diacerein and oxaceprol groups respectively. Tab diacerein 50 mg and oxaceprol 200 mg were prescribed twice daily for three months in respective groups. One patient dropped out in each group, who opted for operative intervention after a few days of enrolment. Efficacy was assessed clinically by WOMAC scale during their follow up at three months. Safety was evaluated clinically considering adverse effects and by complete haemogram & blood biochemistry.
Results: In diacerein-group, WOMAC score (mean ± S.D.) improved from 48.77± 18.17 to 29.40 ± 19.94 (p-value = 0.00001) and in oxaceprol group from 42.59 ± 19.49 to 26.58 ± 16.83 (p-value = 0.00001). No adverse effect was reported in any group.
Conclusion: Both medicines are almost similar in safety and efficacy.

Key words: Diacerein, Oxaceprol, Osteoarthritis of knee.

Doi : 10.18231/2393-9087.2018.0023

How to cite : Sharad S, Kansal D, Sharma V, Sharma P, To compare the safety and efficacy of diacerein and oxaceprol in the management of grade I & II osteoarthritis of knee. Indian J Pharm Pharmacol 2018;5(3):105-109

Copyright © 2018 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)